Thank you, Mr. Chair.
My question is for the representatives from the Canadian Cancer Society, Ms. Masotti and Ms. Seale.
In recommendation 6 in your brief, you call on the federal government to show more leadership and address the inequalities in funding for take-home cancer drugs.
Could you elaborate on that?